Posttranscriptional elevation of cytochrome p450 3A expression

Biochemical and Biophysical Research Communications

Volumn 231, Issue 1, 1997, Pages 203-205

  Zangar, Richard C ^a   Hernandez, Marissa ^a   Novak, Raymond F ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEXAMETHASONE; DIMETHYL SULFOXIDE; LIVER ENZYME; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; LIVER CELL; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031550529     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6054     Document Type: Article

References (11)

1. Martindale. The Extra Pharmacopoeia. 1996;Royal Pharmaceutical Society, London. p. 1399-1400.
2. Bond G. R., Curry S. C. Lancet. 1:1989;1134-1135.
3. Hucker H. B., Miller J. K., Hochberg A., Brobyn R. D., Riordan F. H., Calesnick B. J. Pharmacol. Exp. Therap. 155:1967;309-317.
4. Guengerich F. P. Ortiz de Montellano P. R. Cytochrome P450: Structure, Mechanism, and Biochemistry. 1995;473-535 Plenum Press, New York.
5. Spatzenegger M., Jaeger W. Drug Metab. Rev. 27:1995;397-417.
6. Guengerich F. P., Kim D.-H., Iwasaki M. Chem. Res. Toxicol. 4:1991;168-179.
7. Kim H., Putt D., Reddy S., Hollenberg P. F., Novak R. F. J. Pharmacol. Exp. Ther. 267:1993;927-936.
8. Louis C. A., Wood S. G., Kostrubsky V., Sinclair P. R., Sinclair J. F. J. Pharmacol. Exp. Ther. 269:1994;838-845.
9. Watkins P. B., Wrighton S. A., Schuetz E. G., Maurel P., Guzelian P. S. J. Biol. Chem. 261:1986;6264-6271.
10. Zangar R. C., Woodcroft K. J., Kocarek T. A., Novak R. F. Drug Metab. Dispos. 23:1995;681-687.
11. Zangar R. C., Springer D. L., Buhler D. R. J. Toxicol. Environ. Health. 38:1993;43-55.